SEC Form 4 · accession 0001651844-17-000005
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Jun 22, 2017
Accepted (ET)
Jun 26, 2017 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2017 | P | 5,000 | $3.77 | A | 3,027,550 | D | |
| Common Stock | Jun 23, 2017 | P | 400 | $3.55 | A | 3,027,950 | D | |
| Common Stock | Jun 23, 2017 | P | 600 | $3.56 | A | 3,028,550 | D | |
| Common Stock | Jun 23, 2017 | P | 500 | $3.57 | A | 3,029,050 | D | |
| Common Stock | Jun 23, 2017 | P | 500 | $3.58 | A | 3,029,550 | D | |
| Common Stock | Jun 23, 2017 | P | 1,000 | $3.59 | A | 3,030,550 | D | |
| Common Stock | Jun 23, 2017 | P | 500 | $3.65 | A | 3,031,050 | D | |
| Common Stock | Jun 23, 2017 | P | 600 | $3.73 | A | 3,031,650 | D | |
| Common Stock | Jun 23, 2017 | P | 900 | $3.74 | A | 3,032,550 | D | |
| Common Stock | Jun 26, 2017 | P | 500 | $3.91 | A | 3,033,050 | D | |
| Common Stock | Jun 26, 2017 | P | 1,000 | $3.92 | A | 3,034,050 | D | |
| Common Stock | Jun 26, 2017 | P | 1,500 | $4.00 | A | 3,035,550 | D | |
| Common Stock | Jun 26, 2017 | P | 1,000 | $4.04 | A | 3,036,550 | D | |
| Common Stock | Jun 26, 2017 | P | 500 | $4.05 | A | 3,037,050 | D | |
| Common Stock | Jun 26, 2017 | P | 500 | $4.07 | A | 3,037,550 | D | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust | |
| Common Stock | holding | — | — | — | 49,550 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.